QuickView for CACNA1D;jsessionid=0FFEF0F4A072489E2E369CCD2CD2953D;jsessionid=9A2C76328228F4184EBD8FD5CC27301A;jsessionid=F18899C3F7BF0F42D8BD6F4C5F4AFF10 (gene)

Summary
General Info

Body Atlas

Most Correlated Tissues

Cerebellum peduncles
Skeletal muscle psoas
Atrioventricular node
Cingulate cortex
Tongue

Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

Disorder of adrenal gland
Neurological finding
Infection by Encephalitozoon cuniculi
General adaptation syndrome
Pyloric ulcer

Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

senkirkine
Pyrrolizidine Alkaloids
8-(3-Chlorostyryl)-1,3,7-trimethylxanthine
Carbon Black
Organophosphorus Compounds

Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

TMPRSS2
RBPMS
MARCH6
AXL
HNRNPA0

Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Explore Curated Studies Results

Literature

Most Relevant Literature

CACNA1D-Related Channelopathies: From Hypertension to Autism.
The human channel gating-modifying A749G CACNA1D (Cav1.3) variant induces a neurodevelopmental syndr…
Germline de novo variant F747S extends the phenotypic spectrum of CACNA1D Ca2+ channelopathies.
CACNA1D overexpression and voltage-gated calcium channels in prostate cancer during androgen depriva…
Whole Exome Sequencing Identifies a Heterozygous Variant in the Cav1.3 Gene CACNA1D Associated with …

Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for CACNA1D;jsessionid=0FFEF0F4A072489E2E369CCD2CD2953D;jsessionid=9A2C76328228F4184EBD8FD5CC27301A;jsessionid=F18899C3F7BF0F42D8BD6F4C5F4AFF10

Explore Clinical Trials Results